1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
- Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE Risk Categories
- Thoracic aortic-aneurysm and dissection in association with significant mitral valve disease caused by mutations in TGFB2
- Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey
- Detection and quantification of acute reperfused myocardial infarction in rabbits using DISA-SPECT/CT and 3.0 T cardiac MRI
- Worsening in oxygen saturation and exercise capacity predict adverse outcome in patients with Eisenmenger syndrome
- Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients
- Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD
- Predictive model for late atrial arrhythmia after closure of an atrial septal defect
- Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy
- 2012
- The Ghent Marfan trial: a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers